On November 5, 2024, Neil Peterson, Chief Operating Officer of Merit Medical Systems Inc (MMSI, Financial), sold 5,000 shares of the company at a price of $98 per share. The transaction was documented in an SEC Filing. Following this sale, the insider now owns 14,819 shares of the company.
Merit Medical Systems Inc, a company specializing in the development, manufacture, and distribution of proprietary disposable medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy.
Over the past year, Neil Peterson has sold a total of 12,500 shares and has not purchased any shares. This recent transaction follows a trend observed in the company, where there have been 9 insider sells and no insider buys over the last year.
The shares of Merit Medical Systems Inc were trading at $98 on the day of the transaction, giving the company a market cap of approximately $5.94 billion. The price-earnings ratio of the company stands at 49.74, which is above the industry median of 29.77.
According to the GF Value, the intrinsic value of the stock is estimated at $79.97, which suggests that the stock is Modestly Overvalued with a price-to-GF-Value ratio of 1.23.
This sale by the insider might be of interest to current and potential investors, as it provides insight into the insider's perspective on the stock's valuation and future prospects.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
